PantherFan
@PickingMyOwnI used to kick ass and take names. Then I got tired of taking names.
Similar User
@BostonOmahaNews
@always_invest
@Amarincorp
@buylowsellhighh
@Rakeshre4
@DinoPerlman
@AlexCastro_360
@AireBeam
@greenday_bio
@blue58blue58
@chiragontwtr
@WinnipegInvstr
@BrasstownCowboy
@LoneWolfTwit58
@Bikepeddle
I'm going to post this video every day so we never forget
BREAKING: Hakeem Jeffries just destroyed Donald Trump’s cabinet picks in a matter of moments. Retweet to make sure every American sees this.
Funny how NYPD identified CEO Thompson’s assassin in just 3 days, but after 4 years @FBI with all the human resources, geofencing, technology and surveillance cameras on every corner, can’t ID the DC bomber.
This guy was a big part of Michigan’s MAGA scene. They’re full of degenerates.
Michigan church worship leader & CPAC performer, Zachary Radcliff, who was arrested in October for sexually abusing children in his church, has been charged with 22 new child sex crimes. Radcliff now faces 33 child sex crime charges.
And I believe illegally. He’s a MAJOR contractor with huge sums of money flowing from the government into SpaceX, Starlink and Tesla. And his answer to government excess? Cuts to your services and Social Security.
Just to be super clear, he spent over a quarter of a billion dollars to elect Trump.
JEFF $MREO Valuation: Setrusumab (OI; POS 65%)&alvelestat (AATD-lung; POS 65%) comprises 88%& 12% value, respectively. Using DCF+EPS blend, base $7 PT assumes OI pivotal success @IA2 (launch mid'26), and alvelestat partnering; bull $11 PT w/ IA1
$MREO If Setrusumab is approved, Jefferies sees a launch with no near-term competition and "healthy royalties," sees shares upside. $$7.17 Says 1st interim has a chance, if not the 2nd interim probably will.
$MREO The trading the last month has been a master class in Institutional holders taking shares of frustrated retail.
Piper $RARE P3 portion has multiple interim analyses-Per mgt the higher number of OI sub-type 3 and 4 patients (who are prone to atraumatic fractures) enrolled in the P3 instills further confidence in the study reaching the interim analyses $MREO
$RARE CEO recently noted that most fractures occurred in ORBIT phase 2 before 3 months and AFR separation could occur early in phase 3. Also noted that ~50% of patients are type III/IV in the phase 3 and that they likely needed less than 100 patients for sufficient power.
Jefferies🏁 $MREO at a Buy rating and a $7 price target. Jefferies said in it research note: " $MREO's lead asset setrusumab (partnered w/ $RARE in U.S.) is in ph.Ill for osteogenesis imperfecta (OI) - we believe 2nd interim (w/ p<0.01) will succeed (mid'25), though 1st interim…
Baird~9/18~reit $MREO OP/$8. Remains +VE despite weakness in shrs surrounding BOOST Pharma's update: believes BOOST program doesn't represent a substantial near-term comp threat=differences in the dev timelines/lack of data from Type 1 pts/uncertainties surrounding MOA/IS: $RARE
United States Trends
- 1. Remy 42,3 B posts
- 2. YouTube TV 101 B posts
- 3. $CUTO 7.706 posts
- 4. #Drgreennft N/A
- 5. $LINGO 53 B posts
- 6. Claressa 9.681 posts
- 7. NYSE 49,8 B posts
- 8. gracie 17,8 B posts
- 9. Eazy 6.934 posts
- 10. Person of the Year 206 B posts
- 11. $PHNIX 7.524 posts
- 12. #thursdayvibes 5.590 posts
- 13. YTTV N/A
- 14. Hulu 13,5 B posts
- 15. Cable 22,1 B posts
- 16. #supersoft N/A
- 17. DirecTV N/A
- 18. Zuckerberg 48,1 B posts
- 19. Man of the Year 37 B posts
- 20. Sling 8.195 posts
Who to follow
-
Boston Omaha News
@BostonOmahaNews -
Always Be Investing
@always_invest -
Amarin
@Amarincorp -
Patient_Investor
@buylowsellhighh -
Rakeshre
@Rakeshre4 -
Dino Perlman
@DinoPerlman -
Alex Castro
@AlexCastro_360 -
AireBeam Broadband
@AireBeam -
Money Tree: Investing in Your Future
@greenday_bio -
🍇🫐Sam
@blue58blue58 -
Chirag Shah
@chiragontwtr -
Winnipeg Investor
@WinnipegInvstr -
Brasstown Cowboy
@BrasstownCowboy -
Veni Vidi Vici
@LoneWolfTwit58 -
Adam K
@Bikepeddle
Something went wrong.
Something went wrong.